Senate
Study
Bill
1138
-
Introduced
SENATE
FILE
_____
BY
(PROPOSED
COMMITTEE
ON
HEALTH
AND
HUMAN
SERVICES
BILL
BY
CHAIRPERSON
KLIMESH)
A
BILL
FOR
An
Act
relating
to
a
review
of
anti-obesity
medications
by
the
1
department
of
health
and
human
services
and
the
department
2
of
administrative
services
for
purposes
of
the
medical
3
assistance
program
and
health
insurance
plans
for
public
4
employees.
5
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
6
TLSB
1939XC
(3)
91
lh/ko
S.F.
_____
Section
1.
ANTI-OBESITY
MEDICATION
REVIEW
AND
REPORT.
For
1
purposes
of
the
medical
assistance
program
under
chapter
2
249A
and
health
insurance
plans
established
pursuant
to
3
chapter
509A
for
public
employees,
the
department
of
health
4
and
human
services
and
the
department
of
administrative
5
services
shall
review
anti-obesity
medications,
including
6
GLP-1
agonists,
for
effectiveness
relating
to
weight
loss,
7
the
impact
on
comorbidities,
the
potential
for
cost
savings
8
due
to
deferred
medical
procedures
and
reduced
medications
9
related
to
comorbidity,
recommended
eligibility
requirements,
10
and
any
other
criteria
the
departments
deem
relevant.
The
11
department
of
health
and
human
services
and
the
department
of
12
administrative
services
shall
submit
a
report
to
the
general
13
assembly
by
January
5,
2026,
with
the
departments’
findings
and
14
proposed
eligibility
requirements.
15
EXPLANATION
16
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
17
the
explanation’s
substance
by
the
members
of
the
general
assembly.
18
This
bill
relates
to
the
department
of
health
and
human
19
services
(HHS)
and
the
department
of
administrative
services
20
(DAS)
review
of
anti-obesity
medication
for
purposes
of
21
the
medical
assistance
program
and
health
insurance
plans
22
established
pursuant
to
Code
chapter
509A
for
public
employees.
23
The
bill
requires
HHS
and
DAS
to
review
anti-obesity
24
medications,
including
GLP-1
agonists,
for
effectiveness,
25
comorbidities,
cost
savings,
and
eligibility
requirements
as
26
described
in
the
bill.
HHS
and
DAS
shall
submit
a
report
to
the
27
general
assembly
by
January
5,
2026,
containing
HHS’s
and
DAS’s
28
findings
and
proposed
eligibility
requirements.
29
-1-
LSB
1939XC
(3)
91
lh/ko
1/
1